Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

Pulse Medical and BioMap are among the companies that raised nine-figure rounds, while Amwell bought two corporate-backed companies at once.

SoftBank and Heritage Provider Network were among the investors who co-led a series C round for Intervenn Biosciences, which is developing precision medicine.

Corporate-backed teleconferencing system provider Baijiayun raised cash at a $465m valuation while financial software provider Prime Trust closed a $64m round featuring Nationwide and Samsung Next.

The ultrasound imaging technology developer backed by multiple corporates has completed a series C round that brought its overall funding to $320m.

GV was among the participants in a series C round that boosted the neurological communication technology developer's total funding to more than $360m.

Existing investors Pfizer Ventures and Merck GHI helped the precision cancer test developer take its total funding past the $130m mark.

Samsung-backed robotics software developer Covariant hiked its overall funding to $147m in a round led by returning investor Index Ventures.

Orange Ventures returned in a round that boosted the digital payment technology producer's overall funding to $106m.

SoftBank-backed barbershop booking service Squire raised $60m at a $750m valuation while card issuing platform developer Lithic was valued at $800m in a round featuring Exor.